Bayer microtechnology purchase to form core

Bayer Technology Services (BTS) is strengthening its expertise in the growing microtechnology segment with the acquisition of the business and assets of Ehrfeld Mikrotechnik, based in Wendelsheim, Germany.

Ehrfeld's core business lies in the development, manufacture and marketing of microreactor modules and in process development. Microtechnology makes it possible to exert precise control over complex or critical fine chemical reactions. This not only further improves the safety of chemical production processes, it also means that production units can be operated more efficiently and can also be built smaller and less expensively.

BTS intends to make Ehrfeld Mikrotechnik BTS (EMB) the core in a network of microtechnology service providers and research institutes, which will enable the full exploitation of the potential of microtechnology in the long term. Dr Olaf Stange has been appointed as new managing director of EMB.

'Thanks to the know-how it has acquired with EMB, BTS is now able to offer a full range of services from module development through process and product development to the engineering and construction of entire production units,' said Dr Helmut Mothes, senior vice president, head of process technology at BTS. EMB will continue to supply these products and services to customers on the external market.